MROSS, Klaus et al.
 DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study.
<strong>Vascular Cell</strong>, [S.l.], v. 1, n. 1, p. 5, sep. 2009.
ISSN 2045-824X.
Available at: &lt;<a href="https://vascularcell.com/index.php/vc/article/view/10.1186-2040-2384-1-5" target="_new">https://vascularcell.com/index.php/vc/article/view/10.1186-2040-2384-1-5</a>&gt;. Date accessed: 19 apr. 2024.
doi: <a href="http://dx.doi.org/10.1186/2040-2384-1-5">http://dx.doi.org/10.1186/2040-2384-1-5</a>.